Concord Medical Net Income Over Time

CCM Stock  USD 3.97  0.07  1.79%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Concord Medical Performance and Concord Medical Correlation.
As of the 6th of February 2026, Net Loss is likely to grow to about (418.7 M). In addition to that, Net Loss is likely to grow to about (557.5 M).
Will Health Care Providers & Services sector continue expanding? Could Concord diversify its offerings? Factors like these will boost the valuation of Concord Medical. Projected growth potential of Concord fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concord Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(5.50)
Revenue Per Share
83.728
Quarterly Revenue Growth
(0.08)
Return On Assets
(0.04)
Return On Equity
(0.29)
Understanding Concord Medical Services requires distinguishing between market price and book value, where the latter reflects Concord's accounting equity. The concept of intrinsic value - what Concord Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Concord Medical's price substantially above or below its fundamental value.
It's important to distinguish between Concord Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concord Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Concord Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Specify up to 10 symbols:

Cross Equities Net Income Analysis

Compare Concord Medical Services and related stocks such as Syra Health Corp, Longevity Health Holdings, and INVO Fertility Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AGraham Number
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
SYRA(4.3 K)(4.3 K)(4.3 K)(4.3 K)(4.3 K)(4.3 K)(4.3 K)(4.3 K)(4.3 K)(4.3 K)(4.3 K)(3.3 K)(2.1 M)(2.9 M)(3.8 M)(3.4 M)(3.2 M)
XAGE(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(6.5 M)(9.1 M)(15.4 M)(10.4 M)(9.3 M)(9.8 M)
IVF(7.4 K)(797.5 K)(666.5 K)(760.7 K)(1.7 M)(5 M)(2.1 M)(702.2 K)(3.1 M)(2.2 M)(8.3 M)(6.7 M)(10.9 M)(8 M)(9.1 M)(8.2 M)(7.8 M)
SISI495.2 K5.8 M5.8 M7.8 M7.3 M8.1 M8.5 M7.6 M796.2 K(6.6 M)(31.4 M)(24.6 M)(13.4 M)(22.4 M)(22.4 M)(20.2 M)(19.2 M)
WORX(386.5 K)(386.5 K)(386.5 K)(386.5 K)(386.5 K)(386.5 K)(4.2 M)(12 M)(14.6 M)(11.5 M)(7.4 M)(3.8 M)(1.8 M)(4 M)(1.1 M)(1.3 M)(1.4 M)
CELU(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(1.1 K)(211.9 M)(208.2 M)(100.1 M)14.2 M(196.3 M)(57.9 M)(66.6 M)(69.9 M)
ADTX(213 K)(213 K)(213 K)(213 K)(213 K)(213 K)(213 K)(213 K)(5.7 M)(5.8 M)(9.1 M)(46.4 M)(27.6 M)(32.4 M)(34.4 M)(31 M)(32.6 M)

Concord Medical Services and related stocks such as Syra Health Corp, Longevity Health Holdings, and INVO Fertility Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Concord Medical Services financial statement analysis. It represents the amount of money remaining after all of Concord Medical Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

My Equities

My Current Equities and Potential Positions

Concord Medical Services
CCM
Specialization
Health Care, Health Care Equipment & Services
Business AddressEast Zone, Hanwei
ExchangeNew York Stock Exchange
USD 3.97
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:
Check out Concord Medical Performance and Concord Medical Correlation.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Concord Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Concord Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Concord Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...